» Articles » PMID: 24599889

Instrumental Variable Methods for Causal Inference

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2014 Mar 7
PMID 24599889
Citations 217
Authors
Affiliations
Soon will be listed here.
Abstract

A goal of many health studies is to determine the causal effect of a treatment or intervention on health outcomes. Often, it is not ethically or practically possible to conduct a perfectly randomized experiment, and instead, an observational study must be used. A major challenge to the validity of observational studies is the possibility of unmeasured confounding (i.e., unmeasured ways in which the treatment and control groups differ before treatment administration, which also affect the outcome). Instrumental variables analysis is a method for controlling for unmeasured confounding. This type of analysis requires the measurement of a valid instrumental variable, which is a variable that (i) is independent of the unmeasured confounding; (ii) affects the treatment; and (iii) affects the outcome only indirectly through its effect on the treatment. This tutorial discusses the types of causal effects that can be estimated by instrumental variables analysis; the assumptions needed for instrumental variables analysis to provide valid estimates of causal effects and sensitivity analysis for those assumptions; methods of estimation of causal effects using instrumental variables; and sources of instrumental variables in health studies.

Citing Articles

Exploring the causal relationship between PAH and some autoimmune diseases using bidirectional Mendelian randomization analyses.

Lian H, Chen R, Zeng Y, Guo R, Li D Medicine (Baltimore). 2025; 104(10):e41737.

PMID: 40068029 PMC: 11902968. DOI: 10.1097/MD.0000000000041737.


So Many Choices: A Guide to Selecting Among Methods to Adjust for Observed Confounders.

Keele L, Grieve R Stat Med. 2025; 44(5):e10336.

PMID: 39947224 PMC: 11825193. DOI: 10.1002/sim.10336.


Spatiotemporal effect of internet use on life expectancy: cross-country insight from a geographically and temporally weighted analysis.

Pu H, Kang W, Gao W, Wang S, Wu R, Ren Z BMC Public Health. 2025; 25(1):569.

PMID: 39934763 PMC: 11817067. DOI: 10.1186/s12889-025-21760-1.


A Review of Mendelian Randomization: Assumptions, Methods, and Application to Obesity-Related Diseases.

Lee S, Lee W J Obes Metab Syndr. 2025; 34(1):14-26.

PMID: 39809435 PMC: 11799604. DOI: 10.7570/jomes24031.


Statistical methods to adjust for the effects on intervention compliance in randomized clinical trials where precision treatment rules are being developed.

Zainal N, Benjet C, Albor Y, Nunez-Delgado M, Zambrano-Cruz R, Contreras-Ibanez C Int J Methods Psychiatr Res. 2025; 34(1):e70005.

PMID: 39780444 PMC: 11711205. DOI: 10.1002/mpr.70005.


References
1.
Nie H, Cheng J, Small D . Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring. Biometrics. 2011; 67(4):1397-405. DOI: 10.1111/j.1541-0420.2011.01575.x. View

2.
Aidoo M, Terlouw D, Kolczak M, McElroy P, Kuile F, Kariuki S . Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 2002; 359(9314):1311-2. DOI: 10.1016/S0140-6736(02)08273-9. View

3.
Cole J, Norman H, Weatherby L, Walker A . Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy. 2006; 26(8):1157-64. DOI: 10.1592/phco.26.8.1157. View

4.
DAgostino Jr R . Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17(19):2265-81. DOI: 10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b. View

5.
GOEDDE H, Agarwal D, FRITZE G, Singh S, Beckmann G, Bhatia K . Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet. 1992; 88(3):344-6. DOI: 10.1007/BF00197271. View